Irbesartan Normon (Irbesartan)

Irbesartan works by selectively blocking the angiotensin II type 1 (AT1) receptors. This prevents angiotensin II from causing blood‑vessel constriction and aldosterone release, leading to lower vascular resistance, reduced fluid retention, and a decrease in blood pressure.

The dose of Irbesartan Normon is individualized by the prescribing clinician based on the patient’s blood‑pressure targets, kidney function, and overall health status. Patients should follow the dosage instructions provided by their healthcare professional.

Safety of Irbesartan in pregnancy and lactation has not been established. It is generally avoided in pregnant or nursing women unless the potential benefit justifies the risk, and alternative therapies are considered first.

To order Irbesartan Normon, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan and ACE inhibitors both target the renin‑angiotensin system, but Irbesartan blocks the AT1 receptor downstream of angiotensin II, while ACE inhibitors prevent its formation. Irbesartan is often better tolerated with a lower incidence of cough, but both classes share risks such as hyperkalaemia and renal impairment.

Irbesartan Normon tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Irbesartan Normon is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a glass of water and follow any specific timing instructions given by their prescriber.

Serious risks include angioedema (swelling of the face, lips, tongue or throat), severe hyperkalaemia, acute renal failure, and significant drops in blood pressure. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden weakness, or marked changes in urine output.

Irbesartan Normon should not be used by individuals with known hypersensitivity to irbesartan or any ARB, pregnant women, patients with severe hepatic impairment, or those with a history of angioedema related to renin‑angiotensin system blockers. Clinicians must evaluate each patient’s medical history before prescribing.